Grail (GRAL) Stock Forecast & Price Target

$14.20

-0.12 (-0.84%)

(As of 10/17/2024 ET)

Grail - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 1 Analyst Ratings

Sell
0

Hold
1

Buy
0

Based on 1 Wall Street analysts who have issued ratings for Grail in the last 12 months, the stock has a consensus rating of "Hold." Out of the 1 analysts, 1 has given a hold rating for GRAL.

Consensus Price Target

N/A

Get the Latest News and Ratings for GRAL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Grail and its competitors.

GRAL Analyst Ratings Over Time

Type	Current Forecast 10/18/23 to 10/17/24	1 Month Ago 9/18/23 to 9/17/24	3 Months Ago 7/20/23 to 7/19/24	1 Year Ago 10/18/22 to 10/18/23
Strong Buy	0 Strong Buy rating(s)	N/A	N/A	N/A
Buy	0 Buy rating(s)	N/A	N/A	N/A
Hold	1 Hold rating(s)	N/A	N/A	N/A
Sell	0 Sell rating(s)	N/A	N/A	N/A
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A
Consensus Rating	Hold	N/A	N/A	N/A

Crypto’s next big bull run? (Ad)

Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on November 5. Just a day after the American election, Juan believes crypto could start a massive run up …

And one special coin could do even better.

GRAL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GRAL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Grail Stock vs. The Competition

Type	Grail	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.79	2.50
Consensus Rating	Hold	Moderate Buy	Hold
Predicted Upside	N/A	13,672.28% Upside	6.31% Upside
News Sentiment Rating	Positive News See Recent GRAL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
10/17/2024	Guggenheim 3 of 5 stars		Initiated Coverage	Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:46 PM ET.

GRAL Forecast - Frequently Asked Questions

: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Grail in the last year. There is currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GRAL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GRAL, but not buy additional shares or sell existing shares.
: According to analysts, Grail's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.
: Grail has been rated by research analysts at Guggenheim in the past 90 days.
: Analysts like Grail less than other "medical" companies. The consensus rating for Grail is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how GRAL compares to other companies.